 Clinical immunologic follow-up patients venom immunotherapy self-selected Hymenoptera sting-sensitive patients minimal optimal duration venom immunotherapy VIT clinical immunologic parameters predictive clinical immunity VIT years VIT patients deliberate sting challenges DSCs live insects DSCs patients VIT repeat venom skin tests VSTs DSCs patients possible VST venom-specific antibody Ab levels VIT One-year VIT VST venom-specific IgE IgG Ab level results variable patients tolerated DSC patients generalized reactions patients pre-VIT histories grade IV field-sting reactions VIT years years short-term year risk recurrence clinical allergy stings VIT patients grade IV field-sting reactions VIT versus patients grade III reactions VIT versus patients VIT years versus patients VIT years versus VIT years patients pre-VIT field-sting reactions grade IV severity VST venom-specific Ab results outcome DSC subsequent clinical course individual patients VIT